Lyfgenia / LOVOTIBEGLOGENE AUTOTEMCEL
Description Lyfgenia is a gene therapy used to treat sickle cell disease in patients 12 years and older. It is an autologous hematopoietic stem cell-based gene therapy, meaning it uses the patient’s own stem cells to modify and treat the disease. Consult a doctor for personalized advice before considering Lyfgenia treatment. Indications and Usage Remember … Read more